Desiree  Ralls-Morrison net worth and biography

Desiree Ralls-Morrison Biography and Net Worth

Desiree Ann Ralls-Morrison J.D. serves as Senior Vice President, General Counsel, Corporate Secretary of the Company. In this role, she is responsible for providing global legal leadership across all of our businesses, regions and functions, and overseeing the company's global compliance function. Before joining Boston Scientific, she was senior vice president, general counsel and corporate secretary, and head of the global litigation, government affairs and public policy organizations, for Boehringer Ingelheim USA, Inc. since October 2013. Prior to that, she spent nine years at Johnson & Johnson, most recently as general counsel for the consumer group, and previously progressed through roles of increasing responsibility, including senior counsel, assistant general counsel, and vice president of law for the women's health, nutritionals and over-the-counter businesses. Earlier in her career, Ms. Ralls-Morrison was a senior attorney and assistant counsel at Merck & Co, Inc., focusing largely on regulatory and product liability matters, and prior to that, she held litigation roles at the law firms of Kelley Drye & Warren LLP and Shipman & Goodwin LLP. She recently served on the Danbury Hospital/New Milford Hospital Board of Directors, The Inner-City Foundation for Charity and Education and the Lawyer's Collaborative for Diversity. Desiree earned her B.A. in economics and political science from Wesleyan University and her J.D. from Harvard Law School.

What is Desiree Ralls-Morrison's net worth?

The estimated net worth of Desiree Ralls-Morrison is at least $505,763.53 as of July 11th, 2024. Ms. Ralls-Morrison owns 5,609 shares of Boston Scientific stock worth more than $505,764 as of November 21st. This net worth approximation does not reflect any other assets that Ms. Ralls-Morrison may own. Learn More about Desiree Ralls-Morrison's net worth.

How do I contact Desiree Ralls-Morrison?

The corporate mailing address for Ms. Ralls-Morrison and other Boston Scientific executives is 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA, 01752. Boston Scientific can also be reached via phone at (508) 683-4000 and via email at [email protected]. Learn More on Desiree Ralls-Morrison's contact information.

Has Desiree Ralls-Morrison been buying or selling shares of Boston Scientific?

Desiree Ralls-Morrison has not been actively trading shares of Boston Scientific during the past quarter. Most recently, Desiree Ralls-Morrison sold 4,050 shares of the business's stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $45.50, for a transaction totalling $184,275.00. Learn More on Desiree Ralls-Morrison's trading history.

Who are Boston Scientific's active insiders?

Boston Scientific's insider roster includes Kevin Ballinger (EVP), Supratim Bose (EVP), Daniel Brennan (CFO), Vance Brown (SVP), Arthur Butcher (EVP), Wendy Carruthers (SVP), Nelda Connors (Director), Keith Dawkins (EVP), Charles Dockendorff (Director), Jodi Eddy (SVP), Joseph Fitzgerald (EVP), Edward Ludwig (Director), Edward Ludwig (Director), Edward Mackey (EVP), Michael Mahoney (CEO), Ian Meredith (EVP), Jeffrey Mirviss (EVP), Jonathan Monson (CAO), Maulik Nanavaty (SVP), Scott Olson (SVP), Michael Phalen (EVP), David Pierce (EVP), Timothy Pratt (EVP), Desiree Ralls-Morrison (SVP), Meghan Scanlon (SVP), John Sorenson (SVP), Eric Thepaut (EVP), Xin Wang (SVP), and David Wichmann (Director). Learn More on Boston Scientific's active insiders.

Are insiders buying or selling shares of Boston Scientific?

During the last twelve months, insiders at the medical equipment provider sold shares 21 times. They sold a total of 481,676 shares worth more than $37,970,807.37. The most recent insider tranaction occured on October, 7th when CEO Michael F Mahoney sold 162,777 shares worth more than $13,775,817.51. Insiders at Boston Scientific own 0.5% of the company. Learn More about insider trades at Boston Scientific.

Information on this page was last updated on 10/7/2024.

Desiree Ralls-Morrison Insider Trading History at Boston Scientific

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/2/2020Sell4,050$45.50$184,275.00View SEC Filing Icon  
1/9/2019Sell4,047$36.00$145,692.00View SEC Filing Icon  
See Full Table

Desiree Ralls-Morrison Buying and Selling Activity at Boston Scientific

This chart shows Desiree Ralls-Morrison's buying and selling at Boston Scientific by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Boston Scientific Company Overview

Boston Scientific logo
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Read More

Today's Range

Now: $90.81
Low: $90.33
High: $90.89

50 Day Range

MA: $85.71
Low: $82.52
High: $90.45

2 Week Range

Now: $90.81
Low: $53.93
High: $91.08

Volume

328,679 shs

Average Volume

6,063,119 shs

Market Capitalization

$133.84 billion

P/E Ratio

75.05

Dividend Yield

N/A

Beta

0.79